Abstract-The acute oral toxicity of the anticoagulant rodenticide diphacinone was found to be over 20 times greater in American kestrels (Falco sparverius; median lethal dose 96.8 mg/kg body weight) compared with Northern bobwhite (Colinus virginianus) and mallards (Anas platyrhynchos). Modest evidence of internal bleeding was observed at necropsy, although histological examination of heart, liver, kidney, lung, intestine, and skeletal muscle revealed hemorrhage over a wide range of doses (35.1-675 mg/kg). Residue analysis suggests that the half-life of diphacinone in the liver of kestrels that survived was relatively short, with the majority of the dose cleared within 7 d of exposure. Several precise and sensitive clotting assays (prothrombin time, Russell's viper venom time, thrombin clotting time) were adapted for use in this species, and oral administration of diphacinone at 50 mg/kg increased prothrombin time and Russell's viper venom time at 48 and 96 h postdose compared with controls. Prolongation of in vitro clotting time reflects impaired coagulation complex activity, and generally corresponded with the onset of overt signs of toxicity and lethality.
INTRODUCTION
Several anticoagulant rodenticides have been identified as hazards to predatory and scavenging birds on a worldwide scale. Various targeted surveillance programs have reported high detection rates of anticoagulant rodenticide residues in liver of birds of prey collected in New York (49% of 265 raptors, 1998-2001) [1] , France (73% of 30 raptors, 2003) [2] , Great Britain (37% of 351 owls and kestrels, [2003] [2004] [2005] ; derived from Walker et al. [3] ), and western Canada (70% of 164 owls, 1988-2003) [4] . Although diagnostic residue concentrations associated with adverse effects in raptors have yet to be clearly established, the cause of death was attributed to secondary rodenticide poisoning in up to 14.6% of the exposure incidents [1, 3, 4] .
Monitoring avian species during large-scale rodent eradication operations revealed that several second-generation rodenticides can result in nontarget mortality and even populationlevel effects through direct ingestion of bait or consumption of poisoned rodents. For example, baiting operations using brodifacoum resulted in > 80% reductions in woodhen (Gallirallus australis) populations and loss of some raptors (e.g., Australasian harrier, Circus approximans; morepork, Ninox novaeseelandiae) at Stewart, Ulva, and Inner Chetwode Islands in New Zealand [5, 6] ; the death of 13 ravens (Corvus corax) at Langara Island in British Columbia, Canada [7] ; and, most recently, the apparent poisoning of 320 glaucous-winged gulls (Larus glaucescens) and 46 bald eagles (Haliaeetus leucocephalus) on Rat Island, Alaska (http://alaska.fws.gov/ratislandreviewfinal.pdf). Such rodent eradication operations use formulations and application rates that are atypical of more routine use of second-generation rodenticides. Nonetheless, the global magnitude of nontarget poisoning of wildlife both in pest eradication programs and in the more routine use of rodenticides is unknown, and most events probably go unnoticed or are not reported.
A risk assessment conducted by the U.S. Environmental Protection Agency (U.S. EPA) in 2002 identified several rodenticides that pose significant risk to birds and nontarget mammals, in part because of their toxicity and prolonged retention in liver [8] . Restrictions on the sale, distribution, and packaging of brodifacoum, difethialone, bromadiolone, and difenacoum were subsequently instituted by the U.S. EPA in 2008 (http://www.epa.gov/pesticides/reregistration/ rodenticides/finalriskdecision.htm). This action will likely be offset by expanded use of acute toxicants and other anticoagulant rodenticides, including diphacinone (http://www.regulations.gov/#!documentDetail;D ¼ EPA-HQ-OPP-2006-0955-0003). The hazard of diphacinone to nontarget organisms is inadequately characterized, although significant exposure and mortality suspected to be related to diphacinone have been reported for raptors (snowy owl, Nyctea scandiaca; redtailed hawk, Buteo jamaicensis; and Cooper's hawk, Accipiter cooperii) [1, 9] . Here, we report overt signs of intoxication, histopathological responses, blood clotting time, residues, and lethality following diphacinone administration to American kestrels (Falco sparverius), a well-studied toxicological model species for raptors [10] . These data, in combination with similar measurements in Northern bobwhite (Colinus virginianus), will assist in the development of a pharmacodynamic model and a more complete risk assessment of diphacinone for birds.
MATERIALS AND METHODS

Animals
All animal procedures were approved by the Institutional Animal Care and Use Committee of the Patuxent Wildlife Research Center. American kestrels, propagated at the captive colony at Patuxent [11] , were reared in vinyl-coated wire outdoor flight pens (6.1 m long Â 2.4 m wide Â 2.1 m high) containing a nest box, several perches, feed tray and a bowl of fresh water. Birds were maintained on daily rations of either Classic Bird of Prey diet (Nebraska Brand) supplemented with Vionate 1 (Gimborn US), dead mice (Mus musculus), or dead chicken (Gallus gallus) hatchlings. For toxicity tests, kestrels were moved from flight pens to small outdoor cages (1.2 m long Â 0.8 m wide Â 0.6 m high) with a shade roof, rope perch, food tray and water bowl, where they were housed individually.
Acute toxicity of diphacinone
In range-finding trials, serious problems were encountered because of regurgitation of diphacinone (2-[diphenylacetyl] indan-1,3-dione; CAS 82-66-6; 99.2% purity; Hacco) when administered as a suspension in vegetable oil or as a neat dose in a size-0 gelatin capsule (Eli Lilly). Through an iterative process, a method was developed that minimized regurgitation through repeated administration of small quantities of diphacinone (1-39 mg) as a divided dose over a 24-h period. Briefly, kestrels (body weight 98-127 g) were transferred from flight pens to small cages, acclimated for two weeks, fed Classic Bird of Prey diet, and weighed on the afternoon (1600-1700 h) before dosing. Individual size-4 gelatin capsules were weighed on a top-loading balance (1 mg sensitivity). Neat diphacinone was added to the capsule, which was then reweighed to verify dose. Freeze-dried diet and 5 ml FD&C Blue No. 1 food dye (marker for regurgitation; McCormick) were then added to the capsule. After an overnight fast with water accessible at all times, the capsule was administered to the level of the proventriculus using a modified pilling device (pet piller; Jorgensen Laboratories) and a plastic probe that were both 8 mm in diameter. The capsule was chased with 0.2 ml distilled water delivered with a 16-gauge curved ball-point feeding needle (Popper & Sons). The dosed kestrel was returned to its pen and immediately presented with a highly desired food item (dead chicken hatchling). This dosing procedure was repeated up to three additional times within a 24-h period (i.e., at $0900, 1300, 1700, and 0800 h), with the total daily dose ranging from 35.1 to 675 mg/kg. In total, 19 kestrels (two-year-old adults randomly assigned to dose, sexes divided nearly equally among doses) received diphacinone. Four kestrels that served as controls were similarly treated, except that capsules did not contain diphacinone. This acute toxicity study was conducted between September 14 and October 7, 2009, using a sequential dosing scheme that attempted to minimize the number of test subjects. Ambient temperature ranged from 9 to 298C, which is typical for Maryland, USA, at that time of year. Pens were lined with Kraft paper to monitor regurgitation, and birds were observed daily for overt signs of intoxication several times during daylight for one week. Birds that succumbed during the trial and survivors (euthanized with carbon dioxide) were necropsied. Portions of heart, liver, kidney, lung, spleen, intestine, brain, skeletal muscle, and occasionally other tissues were fixed in phosphate-buffered formalin for histopathological analysis, and the liver was frozen at À208C for residue analysis.
Histopathology
In the acute toxicity study, formalin-fixed tissues were processed (American HistoLabs) using standard procedures [12] . In general, four 4-mm sections per tissue, in steps of 100 mm, were mounted on slides and stained with hematoxylin and eosin. All sections were consistently examined at a magnification of Â 200, and, if abnormalities were observed (e.g., hemorrhage and other lesions), the tissue was re-examined at a magnification of Â 400.
Diphacinone purity and liver residue analysis
Neat diphacinone (5 mg) was dissolved in a volumetric flask with ethyl acetate to a nominal concentration of 1 mg/ml and diluted with a methanol solution containing 5 mM tetrabutylammonium dihydrogen phosphate (TBAP) to a nominal concentration of 50 mg/ml. Samples were analyzed on a C18 column (ODS/H, 4. Kestrel livers were homogenized using liquid nitrogen with a mortar and pestle, and duplicate samples from each homogenate were weighed into digestion vessels. Chlorophacinone was added to each sample to serve as a surrogate standard. Acetonitrile was added to each sample, and samples were extracted at 1258C for 60 min using a microwave-accelerated reaction system (CEM Corporation). Extracts were then decanted into glass tubes and reduced to dryness, and residues were reconstituted in chloroform by vortex mixing and sonication. Hexanes were added to the samples, which were again vortexed and sonicated. Sample extracts were then filtered (0.7 mm glass fiber syringe filters; Whatman), cleaned by loading filtrates onto conditioned (chloroform:hexanes, 2:1) 500 mg/3 ml Strata-X-AW solidphase extraction cartridges (Phenomenex), and eluted with methanolic solution containing 15 mM TBAP. Each eluate was reduced to dryness, reconstituted in mobile phase (50% 5 mM TBAP in pH 8.5 6 mM phosphate buffer/50% methanol), and filtered into vials for RP-HPLC analysis. Diphacinone concentrations were determined using an Agilent 1100 series HPLC system and Gemini C18, 3.0 Â 150 mm, 3-mm column (Phenomenex). The aqueous mobile phase was 5 mM TBAP in pH 8.5 6 mM potassium phosphate, and the organic mobile phase was 5 mM TBAP in methanol. For each 30-ml injection, the methanolic component was maintained at 55% for 7 min, followed by a linear gradient to 77.5% over 10 min, raised to 85% over the next 10 min, and returned to the starting composition for 7.5 min. Diphacinone and surrogate were detected at 325 nm.
Control quail liver samples spiked with diphacinone at nominal concentrations of 0.2 mg/g and 2 mg/g produced surrogate-corrected recoveries AE SD of 144 AE 14% (n ¼ 6) and 109 AE 7% (n ¼ 6), respectively. Chlorophacinone was spiked at a nominal concentration of 3.8 mg/g and used as the surrogate to correct diphacinone recoveries. Surrogate recoveries were 91 AE 4% and 87 AE 2%, respectively, at the two diphacinone spiking levels. No significant interference was observed at the retention time for either diphacinone ($19.5 min) or chlorophacinone ($23 min) in extracted quail livers. The method limit of detection (three times the signal:noise ratio) and method limit of quantitation (10 times the signal:noise ratio) were 0.095 mg/g and 0.317 mg/g, respectively. The precision for duplicate determinations in liver samples (n ¼ 19 dosed kestrels) averaged 20%.
Effects of diphacinone on clotting time
As part of a study to develop a physiologically based pharmacokinetic model, kestrels (94-137 g, 1-to 3-year-old adults) received diphacinone as a single sublethal dose using procedures employed in the acute toxicity trial. Between October 18 and November 2, 2009 (ambient temperature 2-258C), treated birds received 50 mg/kg body weight, and blood was drawn at 6, 24, 48, 96, and 168 h after dosing (n ¼ 2 males and 2 females per sampling time). Controls (n ¼ 2 males and 2 females) received capsules containing only freeze-dried diet and dye, and blood was collected after 168 h. Blood collection entailed drawing a 0.9-ml jugular venipuncture sample into a 1-ml syringe containing 0.1 ml of 3.2% sodium citrate (SigmaAldrich). Blood samples were centrifuged (2,000 g for 5 min), and an aliquot of the citrated plasma ($250 ml) was frozen and stored at À808C for clotting assays. A combination of assays (prothrombin time and Russell's viper venom (RVV) time to determine vitamin K-dependent coagulopathies, fibrinogen concentration to rule out nonspecific influences on clotting time) [13] was used to analyze kestrel samples. Body-weight change over the course of the trial and liver:body weight ratio at sacrifice were also determined in this study.
Prothrombin time
In this assay, excess tissue factor and phospholipid (thromboplastin) interact with plasma factor VII to form an active complex, and through a cascade of reactions fibrinogen is converted to fibrin [13] . Prothrombin time (PT) was determined using a BBL fibrometer (Becton Dickinson). Instrument performance over one year was assessed using human reference samples and Simplastin 1 (rabbit brain thromboplastin; Trinity Biotech); PT values were within the reference range provided by the supplier (mean AE SD of sample level 1: 16.6 AE 0.5 s, n ¼ 8 assays; sample level 2: 35.5 AE 1.67 s, n ¼ 7 assays), and interassay precision (2.1% and 3.9%, respectively) was satisfactory.
Because mammalian thromboplastin does not promote rapid clot formation in avian species, crude chick hatchling thromboplastin (CHT) was prepared [13] [14] [15] . For the assay of citrated kestrel plasma samples, a 50-mg aliquot of CHT was suspended in 2,500 ml of 25 mM CaCl 2 and incubated at 428C for 15 min with intermittent vortexing. The suspension was centrifuged (1,500 g for 20 min), and the supernatant was diluted 1:1 with 25 mM CaCl 2 ($220 mg protein/ml). Kestrel plasma (100 ml) was incubated at 378C for 2 min in a sample cup, and the clotting reaction was initiated by the addition of 200 ml diluted CHT. In preliminary studies, PT of citrated kestrel plasma was related to CHT dilution ( Fig. 1) , and PT of kestrel plasma diluted with 8.3 mM Na/K phosphate buffer (pH 7.2) was relatively stable in reactions containing as little as 50% plasma (Supplemental Data, Fig. S1 ). In these preliminary studies, intraassay precision for duplicate determinations of kestrel plasma was 2.0 AE 2.2% (n ¼ 11), but limited sample volume permitted only a single determination in diphacinone-treated kestrels.
Russell's viper venom time
Russell's viper venom activates factor X in the common pathway of the clotting cascade [13] . Reconstituted RVV factor X activator (American Diagnostica) was diluted 1:10 with imidazole-buffered saline (IBS; 0.0125 M imidazole 0.109 M NaCl, pH 7.4; Sigma-Aldrich) and maintained at room temperature. Kestrel plasma (100 ml) was incubated at 378C for 2 min, and 100 ml of diluted RVV was added and incubated for 15 s. The reaction was initiated with 100 ml 25 mM CaCl 2 , and RVV time (RVVT) was determined [16] . In preliminary studies, RVVT remained relatively stable when kestrel plasma was diluted by as much as 60% with phosphate buffer (Fig. 2) , and intraassay precision for duplicate determinations was 3.4 AE 4.1% (n ¼ 9). Because of limited volume, some plasma samples from diphacinone-treated kestrels were diluted in ; R 2 ¼ 0.99).
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Thrombin clotting time
This assay determines the time taken for fibrinogen to be converted to fibrin [16] . The thrombin clotting time assay is an indicator of fibrinogen concentration in a plasma sample, which is insensitive to deficiency of vitamin K-dependent clotting factors. Fibrinogen deficiency resulting from pathophysiologic conditions or improper sample collection can prolong clotting time, and in rodenticide toxicity studies it is important to verify that fibrinogen concentration is adequate to promote clot formation. Assay reagents included bovine thrombin and human fibrinogen reference material (AMAX Fibrinogen Kit; Trinity Biotech). A fibrinogen standard curve was prepared (65-520 mg/dl), and kestrel plasma samples were thawed a second time and diluted 1:10 with IBS. Diluted plasma (200 ml total volume) was incubated at 378C for 2 min, and the reaction was initiated by the addition of 100 ml of thrombin reagent. Clotting time of each sample was transformed to fibrinogen concentration (mg/dl) from the standard curve. In preliminary studies, intraassay precision for duplicate determinations of kestrel plasma was 1.8 AE 2.2% (n ¼ 9).
Statistical analysis
For the acute toxicity trial, the relation between dose and survival and the median lethal dose (LD50) of diphacinone in kestrels was estimated using probit analysis (SAS Institute). A one-phase exponential decay model (Prism; GraphPad Software) was used to describe the relation between clotting time (PT and RVVT) and dilution of kestrel plasma. To examine the effects of a sublethal dose of diphacinone, body weight change, liver:body weight ratio, PT, RVVT, and thrombin clotting time were tested for homogeneity of variances (F max test) and normality (Shapiro-Wilk test, normal probability plot and descriptive statistics). The measurement endpoints were tested by one-way analysis of variance (ANOVA), and clotting times of diphacinone-treated kestrels (hours postdose) were compared with the control group using Dunnett's test.
RESULTS
Acute toxicity of diphacinone
At necropsy, birds were in good body condition with no evidence of starvation or dehydration. At the highest dosage levels, birds received three capsules containing diphacinone but succumbed before receiving the fourth (and final) capsule of their divided dose, so the actual administered doses were 675, 450, and 300 mg/kg (Table 1) . These individuals appeared subdued, died within 8 to 23 h of receiving the initial capsule of the divided dose, and at necropsy exhibited some macroscopic evidence of hemorrhage, but not frank bleeding. There was no history or evidence of trauma in any of the diphacinonetreated or control birds. Histological examination of tissues revealed microscopic hemorrhage in the heart, liver, kidney, lung, intestine, and skeletal muscle of some individuals (Fig. 3) . At the intermediate doses (266.7 down to 118.6 mg/kg), all birds died within 8 to 47 h, with the exception of a single bird that exhibited signs of intoxication but then recovered. Gross necropsy revealed some evidence of hemorrhage in the gastrointestinal tract, and the liver was often mottled. Microscopically, perivascular hemorrhage in the lung and free blood in the lamia propria of the intestine were consistently found. At 79.0 mg/kg, one of three kestrels died after 27 h. At the lowest doses (52.7 and 35.1 mg/kg), all birds survived but exhibited varying degrees of hemorrhage in liver, lung, lamina propria of the intestine, and spleen. Kestrels that succumbed often exhibited a progression of toxic signs, including losing balance on their perch, standing on the floor of the pen rather than on their perch, being nonreactive when approached, showing subdued behavior, and showing tan urate deposits. All controls survived the 7-d trial and did not exhibit gross or microscopic evidence of hemorrhage other than in the airways (commonly found in birds euthanized with carbon dioxide). Probit analysis indicated that survival of kestrels during the 7-d acute toxicity trial was significantly ( p < 0.023) related to the total administered dose of diphacinone. The LD50 of diphacinone for kestrels was estimated to be 96.8 mg/kg (95% confidence interval 37.9-219 mg/kg), and the slope of the dose-response curve was 6.69 AE 2.94 probit/log 10 .
Kestrels that died within 8 to 23 h received the largest doses of diphacinone and had greater concentrations of diphacinone in liver (32.8-56.3 mg/g wet wt) than birds that died 27 to 47 h postdose (13.4-19.4 mg/g wet wt; Table 1 and Fig. 4 ). Diphacinone appeared to be cleared rapidly from the liver, insofar as kestrels that survived the 7-d trial generally had concentrations < 1 mg/g.
Sublethal exposure and effects on clotting time
All birds receiving a single oral dose of 50 mg diphacinone/ kg (estimated LD10 to LD15) survived to their scheduled time of sacrifice. No overt signs of toxicity were observed, and body weight change and liver:body weight ratio were not affected by diphacinone ( p > 0.10). Two of the twenty-four blood samples were problematic and were excluded. One of these samples had no detectable fibrinogen, and the other sample was poorly drawn. Fibrinogen concentration in the remaining 22 samples was between 41.3 and 160.2 mg/dl and did not differ among sampling times ( p > 0.20). Compared with that in the control group, PT at both 48 and 96 h postdose was significantly prolonged (2.5-fold and 1.6-fold, respectively; p < 0.05, logtransformed data), but by 168 h PT had returned to control levels (Fig. 5) . A similar but more pronounced trend was observed for RVVT, with clotting time prolonged at 48 and 96 h (7.6-fold and 3.3-fold, respectively; p < 0.05, log-transformed data; Fig. 6 ). Notably, one RVVT value at 24 h postdose (173.9 s) was 4.8-fold greater than mean RVVT of controls (mean AE SD, 34.2 AE 4.87 s), which is suggestive of coagulopathy.
DISCUSSION
Lethality and overt toxicity
With a relatively small number of individuals in a sequential acute oral dosing scheme, diphacinone was found to be moderately toxic (LD50 96.8 mg/kg) [17] to American kestrels. At doses that evoked lethality (!79 mg/kg), birds exhibited ataxia and subdued behavior but no signs of external bleeding. Based on the median lethal dose, kestrels were found to be about 20 to 30 times more sensitive to diphacinone than Northern bobwhite (LD50 2,014 mg/kg) [13] and mallards (Anas platyrhynchos; LD50 3,158 mg/kg) [8] .
Although diphacinone is linked to secondary poisoning [1, 9] , only a few controlled studies have examined its toxicity in raptors. In an investigation of golden eagles (Aquila chrysaetos) fed muscle from diphacinone-treated sheep (Ovis aries; muscle contained 2.7 mg diphacinone/kg) for 5 to 10 d, adverse effects were observed at much lower concentrations [18] than in kestrels. One eagle that received a cumulative dose of 1.38 mg/ kg body weight exhibited extreme weakness, and another eagle that received a cumulative dose of 1.08 mg/kg exhibited hemorrhage from a wing and ataxia. However, all eagles survived the trial. In another study, great horned owls (Bubo virginianus) and a saw-whet owl (Aegolius acadicus) were fed diphacinonepoisoned mice (Peromyscus maniculatus; 0.01% diphacinone bait) for 5 d, and barn owls (Tyto alba) were fed diphacinonepoisoned rats (Rattus norvegicus, R. rattus and R. exulans; 0.005% diphacinone bait) for 10 d [19] . Unfortunately, the quantity of diphacinone in the poisoned rodents was not analytically determined. A very rough estimate of the cumulative dose (ignoring absorption, metabolism, and elimination of diphacinone in the rodents) suggests that lethality and severe hemorrhage occurred in great horned owls that consumed mice that had eaten the equivalent of 3 to 4 mg diphacinone/kg of owl weight and a saw-whet owl that had consumed mice that had eaten the equivalent of about 55 mg diphacinone/kg of owl weight (V.M. Mendenhall, personal communication). No overt signs of toxicity were observed in barn owls that consumed rats that had eaten the equivalent of about 14 to 17 mg diphacinone/kg of owl weight. In another investigation, communally housed American crows (Corvus brachyrhynchos) were fed rats poisoned with 0.005% diphacinone for 1 or 6 d (n ¼ 10-11/group) [20] . Based solely on visual observations while determining time activity budgets, it was suggested that about 10 mg of diphacinone was consumed following a single day of exposure, whereas 70 mg of diphacinone was consumed by crows in the 6-d-exposure group. One of the crows exposed for 6 d exhibited blood in the nares and petechial hemorrhages on the cloacal mucosa. There was evidence of lengthened PT in both of the dosed groups compared with controls, but white blood cell counts and clinical plasma chemistries were unaffected. Taken together, these studies in raptors (Falconiformes, Strigiformes) indicate that they are considerably more sensitive to diphacinone than are bobwhite and mallards, and their protection may require more substantial safety margins than afforded by avian game bird species traditionally used in pesticide registration studies. Although many factors may account for differences in the sensitivity of raptors to anticoagulant rodenticides (e.g., vitamin K 2,3-epoxide reductase kinetics and inhibition, rodenticide metabolism and clearance), a recent study demonstrated that hydroxylation rates of warfarin in the great horned owl and snowy owl (Bubo scandiacus) are but a small fraction of that observed in mallards, chickens (Gallus gallus), and laboratory rats [21] .
Histopathology, diphacinone residues, and clotting time Only modest evidence of internal bleeding was apparent at necropsy in diphacinone-dosed kestrels. This is in contrast to findings of several anticoagulant rodenticide dosing trials in raptors that have reported external bleeding and extensive internal hemorrhages at necropsy [18, 19, 22, 23] . Nonetheless, Diphacinone and American kestrels Environ. Toxicol. Chem. 30, 2011 histopathological observations of kestrels document hemorrhage in heart, liver, kidney, lung, intestine, and skeletal muscle over a wide range of doses. Hemorrhage in major organs and vessels was likely to be a contributor to death, if not the definitive cause of mortality. However, histopathological observations alone are generally not considered diagnostic of anticoagulant intoxication [24] . Although the half-life of diphacinone in birds has yet to be reported, data from the present study indicate that it is rapidly cleared from liver, and presumably other tissues. For example, kestrels that succumbed to diphacinone (79 to 675 mg/kg) within 48 h of dosing had liver concentrations exceeding 13 mg/g wet weight, whereas dosed individuals (35.1-79 mg/ kg, and a single bird at 266.7 mg/kg) that survived the 7-d trial had concentrations < 0.8 mg/g. A preliminary estimate of the hepatic diphacinone half-life in kestrels orally dosed with 50 mg/kg suggests an overall half-life of 22 h, with an initial phase (6-48 h postdose) half-life of 7.8 h and terminal phase (48-168 h postdose) half-life of 59.8 h (K.E. Horak, personal communication). The hepatic half-life of diphacinone in laboratory rats is about 3 d [25] , and in pigs (Sus scrofa) the overall half-life is about 5.43 d, with an initial phase (1-3 d) half-life of 1.30 d and a terminal phase half-life of 14.12 d [26] . Taken together, these data suggest that diphacinone is cleared more rapidly in kestrels than in rats and pigs. Tissue concentrations of anticoagulant rodenticides associated with adverse effects in raptors have yet to be definitively established, although hepatic concentrations of 0.1 to 0.2 mg brodifacoum/g wet weight in combination with evidence of hemorrhage have been considered diagnostic of death from secondary rodenticide poisoning [1, 4] . Notably, tissue concentrations of anticoagulant rodenticides are likely much greater in acute toxicity studies than in rodenticide-poisoned wild birds (N.B. Vyas, U.S. Geological Survey, Patuxent Wildlife Research Center, Beltsville, MD, personal communication), although histological evidence of hemorrhage in lung and liver of kestrels was apparent at 0.263 and 0.280 mg diphacinone/g wet weight of liver, which is just above the diphacinone method limit of detection.
Anticoagulant rodenticides irreversibly inhibit vitamin K epoxide reductase that is necessary for post-translational carboxylation of the prothrombin group of serine protease coagulation factors (factors II, VII, IX, and X), and without the carboxyl group these factors do not assemble on cell surfaces to form active coagulation complexes [27] . Detection of vitamin K-dependent coagulopathy in kestrels employed a combination of assays [13] , namely, PT and RVVT, that reflect effects on clotting factors (for review see Powers [28] ) and measurement of fibrinogen to rule out improper sample collection and other pathophysiologic conditions (e.g., hepatic synthetic failure, disseminated intravascular coagulation) that can affect clotting time [29] . Prolonged clotting time was apparent at 48 h following administration of a single oral 50 mg diphacinone/kg dose to kestrels, remained elevated at 96 h postdose, and clearly exceeded the 25% increase above reference PT values that is suggestive of anticoagulant exposure [30] . The lag time between dosing and development of coagulopathy reflects the half-life clearance of functional coagulation factors (halflife of factors II, VII, IX, and X in humans are 120, 6, 18, and 65 h, respectively ([31] ; see http://www.r2diagnostics.com/ cascade_r2/r2.cascade2007.pdf) and increasing circulation of des-carboxy dysfunctional factors. Notably, the onset of prolonged PT and RVVT corresponds with, and may even precede, overt toxicity and lethality at the doses used in the acute toxicity studies. A similar time course of coagulopathy was observed in a small trial in which kestrels received 50 mg/kg as a divided dose (four capsules administered over a 24-h period) [32] . In the study of golden eagles fed meat from diphacinone-treated sheep [18] , overt signs of toxicity appeared to correspond to prolonged PT, and several other studies in various species of birds have documented prolonged clotting within days of gavage or dietary exposure to anticoagulant rodenticides [33] [34] [35] [36] (K.H. Webster, 2009, Master's thesis, Simon Fraser University, Burnaby, BC, Canada).
Risk evaluation
As part of a Special Local Needs pesticide registration (FIFRA Section 24c) for broadcast application of diphacinone (0.005% in a grain-based pellet) for the control of rodents and wild pigs in Hawaii, its hazard to various species of birds was evaluated by both deterministic [37] and probabilistic [38] risk assessments. Using the greatest quantity of diphacinone found in a pig liver (3.07 mg/kg) and the available toxicity data for game birds (LD50 > 400 mg/kg for bobwhite), Eisemann and Swift [37] estimated the quantity of pig liver that would have to be scavenged by a Hawaiian hawk (Buteo solitarius; Federally listed as endangered) or a Hawaiian short-eared owl (Asio flammeus sandwichensis; State of Hawaii listed as endangered) to receive a median lethal dose would be 58.6 kg and 45.6 kg, respectively. Because diphacinone is now known to be less toxic to game birds (LD50 2,014 mg/kg for bobwhite and LD50 3,158 for mallard) [8, 13] , the quantity of pig liver that would have to be scavenged by these Hawaiian raptors would be even greater than originally estimated [37] . As a preliminary effort to refine this risk assessment, we used the acute toxicity data for American kestrels (LD50 96.8 mg/kg) from the present study. It is unlikely that the Hawaiian hawk or short-eared owl would frequently scavenge pigs, so we employed hepatic diphacinone residue data from field trials in Hawaii involving black rats (Rattus rattus; extreme value ¼ 12 mg/kg) that would more likely be consumed by the Hawaiian hawk and house mice (Mus musculus; extreme value ¼ 3.8 mg/kg) that would more likely be consumed by the short-eared owl (E.B. Spurr, U.S. Geological Survey, Pacific Island Ecosystem Research Center, Honolulu, HI, unpublished data).
Using the aforementioned diphacinone potency estimates for kestrels and rodent liver residue data in a deterministic approach [37] , a 0.45-kg Hawaiian hawk would have to consume 3.63 kg of liver from black rats and a 0.35-kg short-eared owl would have to consume 8.92 kg of liver from house mice in order to ingest an acute median lethal dose in a 24-h period (Supplemental Data, Table S1 ). If sublethal effects in kestrels were considered (e.g., 50 mg/kg prolonged PT and RVVT, and 35.1 mg/kg produced microscopic hemorrhages), the amount of rodent liver consumed within a 24-h period would be even lower, 1.32 kg for the hawk and 3.24 kg for the short-eared owl. These quantities of liver are far greater than the weight of both the Hawaiian hawk and short-eared owl, so the risk associated with a single-day exposure to diphacinone would be low. However, applying the kestrel dose-response curve for lethality and the rodent liver residue data in the probabilistic-based 1-d exposure model described by Johnston et al. [38] , 50% of male Hawaiian hawks would have a 1% probability of mortality if they consumed 0.0035 kg of liver from diphacinone-poisoned rats (Supplemental Data, Fig. S2 ). Likewise, 50% of the male Hawaiian short-eared owls would have a 1% probability of mortality if they consumed 0.0044 kg of mouse liver (Supplemental Data, Fig. S3 ). Because the dose-response curve does not permit an estimate of zero probability of lethality, the LD01 was used as a surrogate metric for the no-effect level. For most wildlife populations, toxicant exposures associated with the LD01 would likely have little impact on population viability, although for endangered species this approach may be valid, insofar as regulations (e.g., Endangered Species Act) do not permit adverse impacts on such species. If the objective of natural resource managers is to ensure the viability of a particular wildlife species, the relative harm of rodenticides should be compared with the estimated rodent-induced population effects in the absence of such control.
Given the data for the lowest lethal dose (LLD) for repeated dietary exposures in mallards (LLD ¼ 0.6 mg/kg/d) [37] (R. Long, Wildlife International, Easton, MD, USA, unpublished data) and the liver residue data from black rats and house mice, adverse effects could occur if consumption by the hawk exceeded 0.022 kg of rat liver/d and if consumption by the short-eared owl exceeded 0.055 kg of mouse liver/d, suggesting that repeated exposure would constitute a moderate risk to these species (Supplemental Data, Table S1 ). Furthermore, prolonged PT in 5-and 10-d feeding trials in golden eagles [18, 37] occurred following ingestion of 0.11 mg diphacinone/kg/d, suggesting that the lowest observed effect level for the hawk and short-eared owl could be 0.004 kg of rodent liver/d and 0.010 kg of rodent liver/d, respectively. Under this scenario, the quantities of liver are < 5% of the body weight of these raptors (viz. 4 g is 0.9% of hawk body weight and 10 g is 2.9% of owl body weight), so the Hawaiian hawk and short-eared owl would be at substantial risk of sublethal exposure. In view of the paucity of threshold effects data following repeated daily exposure of raptors to diphacinone, additional feeding trials in kestrels and owls are warranted to characterize better the uptake, tissue half-life, PT and RVVT responses, other potential adverse effects, and overall risk to birds of prey.
CONCLUSIONS
Diphacinone was found to be considerably more toxic to American kestrels than previously reported in traditionally used avian wildlife test species. Sublethal effects on blood clotting were detected at a dose of 50 mg/kg, and histological evidence of hemorrhage was observed at 35.1 mg/kg. Measurement of diphacinone residues in liver suggest that its half-life may be shorter than that reported for rats and pigs. Recent restrictions on the use of some second-generation anticoagulant rodenticides (http://www.epa.gov/pesticides/reregistration/rodenticides/finalriskdecision.htm) may result in increased diphacinone application. In conjunction with its implication in some mortality events in raptors [1, 9] , and the paucity of threshold effects data following repeated daily exposure for birds of prey, additional feeding trials with diphacinone and other more toxic anticoagulant rodenticides (e.g., brodifiacoum) in captive American kestrels and Eastern screech-owls are warranted to characterize better the risk of secondary poisoning.
SUPPLEMENTAL DATA Table S1 . Acute and sublethal dietary risk to birds from secondary poisoning by consumption of contaminated rodents. (36 KB PDF) Fig. S1 . Effect of diluting citrated kestrel plasma with phosphate buffer (100, 60, 40, 20, and 15% plasma) on prothrombin time (Y ¼ 9,605 þ 16,289e
À0.321(%plasma)
; R 2 ¼ 0.99). Fig. S2 . Probability mortality curve (LD01) of Hawaiian hawk consuming diphacinone-poisoned black rats. a Calculated values are the quantities of food required to be ingested to equal the lowest reported avian lethal dose, 50% (LD50), lowest lethal dose (LLD) and lowest-observed-effect level (LOEL).
b Based on median lethal dose for American kestrel (present study).
d Based on lowest lethal dose in mallard acute dietary toxicity study (unpublished data, Long R, Wildlife International, Easton MD, USA).
e Based on lowest observed effect level for prolonged blood clotting time in golden eagles [18] .
c Based on greatest diphacinone residue found in black rat liver (12 mg/kg) that could be consumed by an Hawaiian hawk in a 24 h period, and greatest residue found in house mouse liver (3.8 mg/kg) that could be consumed by an Hawaiian short-eared owl in a 24 h period (unpublished data, Spurr EB, U.S. Geological Survey, Pacific Island Ecosystem Research Center, Honolulu, HI, USA). 
